Evaluating the Effectiveness of Treatment for Metacognition in Moderate and Severe Traumatic Brain Injury
NCT ID: NCT03169647
Last Updated: 2019-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2017-08-17
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
NCT04199130
Functional Connectivity Measurement After Severe Traumatic Brain Injury
NCT02647996
Strategy + RehaCom for Memory Rehabilitation in Traumatic Brain Injury (TBI)
NCT04239456
Evaluation of Well-being Interventions in Adults With TBI
NCT05943756
Rehabilitation of Executive Functioning in Veterans With PTSD and Mild TBI
NCT01921179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
listening-based protocol (type A)
Listening-based intervention
Participants will listen to pre-specified material on a CD
Control
listening-based protocol (type B)
Listening-based intervention
Participants will listen to pre-specified material on a CD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Listening-based intervention
Participants will listen to pre-specified material on a CD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between the ages of 18 and 59.
* able to read and speak English fluently.
* TBI at least 1 year ago.
Exclusion Criteria
* left-handed.
* color-blind.
* diagnosed with significant psychiatric illness (e.g., bipolar, schizophrenia).
* receiving or have received inpatient and/or rehabilitative treatment for substance use.
* diagnosis of a neurological condition other than TBI (e.g., epilepsy, multiple sclerosis, stroke).
* any metal in my body that has not been declared MRI-safe by my physician.
* impaired independent use of either hand.
* any of the following in/on my body that may interfere with MRI: pacemaker, implanted electrical devices, brain stimulators, particular types of dental implants, aneurysm clips, metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids), permanent eyeliner, implanted delivery pumps, or shrapnel fragments.
* history of engaging in welding and/or metal working activities.
* formal training or am a current practitioner of yoga, meditation, and/or mindfulness.
* currently involved in any other type of thinking skills and/or emotional treatment, such as psychotherapy.
18 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kessler Foundation
East Hanover, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-936-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.